In the following chart, we are able to follow ... range of $60.0 to $100.0 over the last 30 days. Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients.

Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...

DexCom receives a warning letter from the FDA citing several issues with its popular G6 & G7 sensor manufacturing. The ...

The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...